Clinical Guidelines for Celiac Disease in Children: What Does It Mean to the Pediatrician/Family Practitioner?

Abstract

Get full access to this article

View all access options for this article.

References

Hill I , Dirks M , Liptak G , et al. Guideline for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1-19.

Fasano A , Berti I , Gerarduzzi T , et al. Prevalence of celiac disease in at-risk and not at-risk groups in the United States. Arch Intern Med. 2003;163:286-292.

Catassi C , Fabiani E , Ratsch I , et al. The celiac iceberg in Italy: a multicentre antigliadin antibodies screening for celiac disease in school-age subjects. Acta Paediatr Suppl. 1996;412:29-35.

Korponay-Szabo I , Kovacs J , Czinner A , et al. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr. 1999;28:26-30.

Maki M , Mustalahti K , Kokkonen J , et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517-2524.

Hoffenberg EJ , Mackenzie T , Barriga KJ , et al. A prospective study of the incidence of childhood celiac disease. J Pediatr. 2003;143:308-314.

Mazzilli MC , Ferrante P , Mariani P , et al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ (alpha l*0501, beta l*0201) heterodimer. Hum Immunol. 1992;33: 133-139.

Spurkland A , Ingvarrson G , Falk ES , et al. Dermatitis herpetiformis and celiac desease are both primarily associated with HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ(alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens. 1997;49:29-34.

Maki M , Huupponen T , Holm K , Hall-strom O. Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus. Gut. 1995;36:239-242.

10.

Saukkonen T , Savilahti E , Reijonen H , et al. Coeliac disease: frequent occurrence after clinical onset of insulin dependent childhood diabetes in Finland Study Group. Diabet Med. 1996;13:464-470.

11.

Barera G , Bonfanti R , Viscardi M , et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics. 2002;109:833-838.

12.

Csizmadia CG , Mearin ML , Oren A , et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr. 2000;137:756-761.

13.

Vitoria JC , Arrieta A , Arranz C , et al. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr. 1999;29:571-574.

14.

Burgin-Wolff A , Berger R , Gaze H , et al. IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr. 1989;148:496-502.

15.

Burgin-Wolff A , Gaze H , Hadziselimovic F , et al. Antigliadin and antiendomysium antibody determination for celiac disease. Arch Dis Child. 1991;66:941-947.

16.

Bode S , Weile B , Krasilnikoff PA , Gudmand-Hoyer E. The diagnostic value of the gliadin antibody test in celiac disease in children: a prospective study. J Pediatr Gastroenterol Nutr. 1993;17:260-264.

17.

Carroccio A , Iacono G , Montalto G , et al.

Immunologic and absorptive tests in celiac disease: can they replace intestinal biopsies?

Scand J Gastroenterol. 1993;28:673-676.

18.

de Lecea A , Ribes-Koninckx C , Polanco I , Calvete JF. Serological screening (antigliadin and antiendomysium antibodies) for non-overt celiac disease in children of short stature. Acta Paediatr Suppl. 1996; 412:54-55.

19.

Lerner A , Kumar V , Iancu TC. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol. 1994;95:78-82.

20.

Bonamico M , Tiberti C , Picarelli A , et al. Radioimmunoassay to detect anti-transglutaminse autoantibodies is the most sensitive and specific screening method for celiac disease. Am J Gastroenterol. 2001;96:1536-1540.

21.

Baldas V , Tommasini A , Trevisiol C , et al. Development of a novel rapid noninvasive screening test for celiac disease. Gut. 2000;47:628-631.

22.

Stern M. Comparitive evaluation of serologic tests for celiac disease: a European initiative toward standardization. J Pediatr Gastroenterol Nutr. 2000;31:513-519.

23.

Sulkanen S , Halttunen T , Laurilla K , Kolho K. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998;115: 1322-1328.

24.

Dietrich W , Laag E , Bruckner-Tuderman L , et al. Antibodies to tissue transglutaminse as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999;113:133-136.

25.

Fabiani E , Catassi C , Villari A , et al. Dietary compliance in screening-detected coeliac disease adolescents. Acta Paediatr. 1996;412(Suppl):65-67.

26.

Logan RFA , Rifkind EA , Turner ID , Ferguson A. Mortality in celiac disease. Gastroenterology. 1989;97:265-271.

27.

Holmes GK , Prior P , Lane MR , et al. Malignancy in coeliac disease: effect of a gluten free diet. Gut. 1989;30:333-338.

28.

Corrao G , Corazza GR , Bagnardi V , et al. Club del Tenue Study Group . Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356-361.

29.

Asking J , Linet M , Gridley G , et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002; 123:1428-1435.